Arterial and venous thrombosis in patients with von Willebrand's disease: A critical review of the literature

Journal of Thrombosis and Thrombolysis

Volumn 21, Issue 2, 2006, Pages 175-178

  Girolami, Antonio ^a   Tezza, F ^a   Scapin, M ^a   Vettore, S ^a   Casonato, A ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Bleeding; Congenital deficiency; Thrombosis; von Willebrand's disease

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTERIOGRAPHY; ARTERY THROMBOSIS; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE CLASSIFICATION; DYSLIPIDEMIA; FEMALE; HEART INFARCTION; HEMOPHILIA A; HEMOPHILIA B; HUMAN; LUNG EMBOLISM; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PHLEBOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING HABIT; VEIN THROMBOSIS; VON WILLEBRAND DISEASE;

HUMANS; PULMONARY EMBOLISM; RISK FACTORS; THROMBOPHILIA; THROMBOSIS; VON WILLEBRAND DISEASE;

EID: 33645875295     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-5732-0     Document Type: Review

References (29)

1. Rosendaal FR, Briet E, Stibbe J, et al. Haemophilia protects against ischaemic heart disease: A study of risk factors. Br J Haematol 1990;75:525-530.
2. Martinelli I. Von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis. Sem Hematol 2005;42:49-55.
3. Girolami A, Randi ML, Ruzzon E, Zanon E, Girolami B. Myocardial infarction, other arterial thrombosis and invasive coronary procedures in haemophilia B patients: A critical evaluation of reported cases. J Thromb Thrombol 2005;20:43-46.
4. Nowak-Gottl U, Escuriola C, Kurnik K, et al. Haemophilia and thrombophilia. What do we learn about combined inheritance of both genetic variations? Hamostaseologie 2003;23:36-40.
5. Van Dijk K, Van der Bom JG, Fischer K, Grobbee DE, Van den Berg HM. Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature. Thromb Haemost 2004;92:305-310.
6. Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases. Medicine 1982;62:248-255.
7. Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B. Myocardial infarction and other arterial occlusions in haemophilia A patients: A cardiological evaluation of all 41 reported cases. Acta Haemat (in press).
8. Girolami A, Randi ML, Ruzzon E, Zanon E, Girolami B. Myocardial infarction. J Thromb Thr 2005;20:43-46.
9. Silwer J, Cronberg S, Nilsson IM. Occurrence of arteriosclerosis in von Willebrand's disease. Acta Med Scand 1966;180:475-484.
10. Dulhoste MN, Bonnet J, Vergnes C, Choussat A, Bricaud H. Maladie de Willebrand at atherosclerose coronarienne. Arch Mal Coeur 1989;82:1875-1878.
11. Franchini M, Veneri D. Are only haemophiliacs protected against ischemic heart disease? Thromb Haemost 2004;92:1455-1455.
12. Grainge C, Nokes T. Cerebral arterial thrombosis in a young woman following vasopressin for von Willebrand's disease. Thromb Haemost 2004;93:380-380.
13. Petäjä J, Rasi V, Myllyla G, Vahtera E, Hallman H. Familial hypofibrinolysis and venous thrombosis. Brit J Haematol 1989;71:393-398.
14. Bowen D, Dasani H, Yung B, Bloom A. Deep venous thrombosis and pulmonary embolism in a patient with type III von Willebrand's disease, protein C and antithrombin III deficiency. Brit J Haematol 1992;81:446-447.
15. Makris M, Colvin B, Gupta V, Shields ML, Smith MP. Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand's disease. Thromb Haemost 2002;88:387-388.
16. Mannucci PM. Venous thromboembolism in von Willebrand disease. Thromb Haemost 2002;88:378-379.
17. Mannucci PM, Chediak J, Hanna W, et al. Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: A prospective, multicenter study. Blood 2002;99:450-456.
18. Franchini M, Krampera M, Veneri D. Deep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genes. Thromb Haemost 2003;90:963-996.
19. Casonato A, Pontara E, Soldera C, Bertomoro A, Girolami A. (Unpublished observations).
20. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152-155.
21. Federici AB, Mannucci PM, Fogato E, Ghidoni P, Matturri L. Autopsy findings in three patients with von Willebrand disease type IIB and type III: Presence of atherosclerotic lesions without occlusive arterial thrombi. Thromb Haemost 1993;70:759-761.
22. Badimon L, Steele P, Badimon JJ, Bowie EJ, Fuster V. Aortic atherosclerosis in pigs with heterozygous von Willebrand disease. Comparison with homozygous von Willebrand and normal pigs. Arteriosclerosis 1985;5:366-370.
23. Fuster V, Lie JT, Badimon L, Rosemark JA, Badimon JJ, Bowie EJ. Spontaneous and diet-induced coronary atherosclerosis in normal swine and swine with von Willebrand disease. Arteriosclerosis 1985;5:67-73.
24. Bilora F, Boccioletti V, Zanon E, Petrobelli F, Girolami A. Hemophilia A, von Willebrand disease, and atherosclerosis of abdominal aorta and leg arteries: Factor VIII and von Willebrand factor defects appear to protect abdominal aorta and leg arteries from atherosclerosis. Clin Appl Thromb Hemost 2001;7:311-313.
25. Bilora F, Dei Rossi C, Girolami B, et al. Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scan. Clin Appl Thromb Hemost 1999;5:232-235.
26. Srämek A, Reiber JHC, Gerrits WBJ, Rosendaal FR. Decreased coagulability has no clinically relevant effect on atherogenesis. Circulation 2004;104:762-767.
27. Srämek A, Bucciarelli P, Federici AB, et al. Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis. Circulation 2004;109:740-744.
28. Girolami A, Cliffton E, Agostino D. Hypercoagulable state induced in humans by the intravenous administration of purified ellagic acid. Thromb Diath Haemorrh 1967;17:165-175.
29. Korninger C, Niessner H, Lechner K. Impaired fibrinolytic response to DDAVP and venous occlusion in a sub-group of patients with von Willebrand's disease. ThrombRes. 1982;23:365-374.